LUMIGAN® 0.01% is covered by many insurance companies and
Medicare. In this section, we’ll review some of the basics about insurance
coverage and how to keep an eye on your costs, including how to get
assistance if you are unable to pay for your medication. There is also a
rebate available for LUMIGAN® 0.01% ophthalmic solution.
If you have not signed up for this helpful rebate yet, click here.
Please note that limitations apply—see rebate for details.
Commercial insurance versus Medicare
There are two types of insurance that you may have:
- Commercial or private insurance: This type of medical insurance
is usually provided by your employer, or you may pay for this insurance yourself
(self-insured). Your coverage generally includes prescriptions.
- Medicare: Medicare is provided by the US government to seniors
and younger adults who meet certain criteria (for example, people with disabilities
also rely on Medicare). Prescription drug coverage is provided under the
Medicare Part D program. For more information about Medicare coverage, including
available prescription drug plans, visit www.Medicare.gov.
What you pay at the pharmacy: your "co-pay"
Co-pays are the amount you have to pay for prescriptions once you have met your
deductible. The amount you pay depends on the list of drugs that your insurance
company covers. This list is called a “formulary.” Insurance companies categorize
drugs into tiers based on cost and other considerations.
Drugs in the first 2 tiers are referred to as "preferred status" or "preferred tier" drugs, and usually have a lower
co-pay—which means fewer out-of-pocket expenses for you.
Different brands within the same class of drugs may have different co-pays based
on their formulary status. Co-pays are an important consideration when selecting
a glaucoma treatment. Formularies are different among insurance plans, so it’s
a good idea to ask your eye doctor, call your insurance company, or visit www.fingertipformulary.com to learn more.
Allergan, the maker of LUMIGAN® 0.01%, participates
which helps eligible, low-income US residents obtain free or low-cost prescriptions.
RxHope® is supported by both the Pharmaceutical Research and Manufacturers
of America (PhRMA) and participating pharmaceutical companies. RxHope® is today's
largest, independent, web-based patient-assistance program resource, processing
and fulfilling thousands of requests every day. For more information, please visit www.RxHope.com.
LUMIGAN® 0.01% (bimatoprost ophthalmic solution) is used
for the treatment of high eye pressure, also called intraocular pressure (IOP),
in people with open-angle glaucoma or ocular hypertension.
Important Safety Information
LUMIGAN® 0.01% (bimatoprost ophthalmic solution) has been
reported to cause darkening (pigmentation) of eye color, eyelid skin, and eyelashes
as well as increased growth of eyelashes. Pigmentation changes can increase as long
as LUMIGAN® 0.01% is used. After stopping LUMIGAN®
0.01%, darkening of eye color is likely to be permanent, while darkening
of the eyelid skin and eyelash changes may be reversible. The effects of increased
darkening beyond 5 years are not known.
When only one eye is treated, there is a possibility of eyelash changes in the eye
treated with LUMIGAN® 0.01%. These changes may result in
differences between the eyes in eyelash length, thickness, darkness, number of eyelashes,
and/or direction of eyelash growth. These changes are usually reversible upon stopping
LUMIGAN® 0.01% therapy.
Avoid allowing the tip of the dispensing bottle to touch the eye, anything around
the eye, fingers, or any other surface in order to avoid contamination by common
bacteria known to cause eye infections. Serious damage to the eye and loss of vision
may result from using contaminated solutions.
If you have eye surgery or develop any eye reactions (such as trauma or infection),
immediately consult with your physician about continuing the use of LUMIGAN®
If you wear contact lenses, remove them before using LUMIGAN® 0.01%.
Then wait 15 minutes after using LUMIGAN® 0.01% before you put your contacts back into your eyes.
The most common side effects are eye redness, growth of eyelashes, and itchy eyes.
for full prescribing information.
This site is intended for US residents only. No information on this site is provided with the intention to give medical advice or instructions on the accurate use of Allergan products. Allergan cannot answer unsolicited emails requesting personal medical advice; visitors should always consult a healthcare professional. Please visit the Allergan site for your country of residence for information concerning Allergan products and services available there.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.